VIRX: Pendapatan perusahaan viracta.com

Lambang korporat lan logo Viracta Therapeutics, Inc. (VIRX)

The Viracta Therapeutics (VIRX) business model relies on outsourcing drug synthesis through CMOs; therefore, this chart on GURU.Markets contains the company's consolidated sales in accordance with strict compliance standards, and the 0.00 value shows the most recent figure. The development of drugs for viral tumors creates a unique niche. A patent monopoly on "killer genes" for treating EBV diseases ensures high margins for the biotech firm.

Pendapatan perusahaan viracta.com (VIRX): kanggo periode 04.07.2022 - 16.02.2025

Rincian metrik komprehensif lan analitis viracta.com (VIRX)

Analisis umum perusahaan:Viracta Therapeutics, Inc., VIRX
Barang utama Viracta Therapeutics

Viracta Therapeutics (VIRX) is focusing on obtaining approval for its lymphoma drug and securing commercial partners, making current cash flows critical. Analyzing the company's sales metrics allows for the tracking of daily inflows, identifying cooling demand or a fundamental weakening of the business. Monitoring this metric helps conduct timely stress testing and avoid purchasing the asset at its peak, thereby minimizing the risk of capital drawdown.

Pesaing wigati

Pendapatan perusahaan ONC|Pendapatan lan volume dodolan HALO|RVMD (Revolution Medicines, Inc.) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Ascentage Pharma Corp AAPG|Total volume dodolan perusahaan CG Oncology, Inc.|URGN - Pendapatan perusahaan|Bicara Therapeutics Inc. (BCAX) - Dodolan perusahaan|Personalis Inc (PSNL) - Pendapatan perusahaan|ERAS - Pendapatan reged perusahaan|DCTH (Delcath Systems Inc) - Pendapatan lan volume dodolan|Pendapatan perusahaan YMAB|Pendapatan lan volume dodolan AURA|Pendapatan perusahaan CADL (Candel)|Accuray, Inc. - Dodolan perusahaan|SELLAS Life Sciences Group Inc. - Pendapatan perusahaan|ACTU: Dodolan perusahaan|Total pendapatan perusahaan Citius Oncology Inc|HURA: Pendapatan lan volume dodolan|TARA: Total dodolan perusahaan|FATE (fatetherapeutics.com) - Pendapatan lan volume dodolan|Dodolan perusahaan Aadi Bioscience Inc (WHWK)|Pendapatan lan volume dodolan TCRX|CSBR - Total pendapatan perusahaan|Pendapatan lan volume dodolan XBIT (XBiotech Inc.)|CEL-SCI Corporation (CVM) - Total pendapatan perusahaan|OSTX: Dodolan perusahaan|Pendapatan dodolan perusahaan RADX (Radiopharm Theranostics)|Artiva (ARTV) - Pendapatan perusahaan|ANL: Total dodolan perusahaan|VERU (Veru Corporation) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Tempest Therapeutics, Inc. TPST|Pendapatan lan volume dodolan XLO|Renovaro - Volume dodolan perusahaan|Pendapatan perusahaan Mural Bio MURA|KAPA: Volume dodolan perusahaan|OnKure Therapeutics - Pendapatan lan volume dodolan|Pendapatan reged perusahaan w2.cytomed.sg GDTC|CRIS: Pendapatan lan volume dodolan|Dodolan perusahaan Apollomics Inc.|THAR (Tharimmune Corporation) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Advanced Biomed Inc|Pendapatan lan volume dodolan GNPX|Dodolan perusahaan Calidi Biotherapeutics Inc. CLDI|Pendapatan perusahaan Sunshine Biopharma Inc. SBFM|Pendapatan reged perusahaan Xenetic Biosciences (XBIO)|SLRX - Pendapatan perusahaan|Total pendapatan perusahaan Kitov Pharma|AON (AONC) - Pendapatan perusahaan|Dodolan perusahaan BeiGene|Pendapatan perusahaan checkpointtx.com|Volume dodolan perusahaan ELEV (Elevation Oncology)|Pendapatan lan volume dodolan ICAD|Ikena Oncology - Volume dodolan perusahaan|Pendapatan perusahaan Notable Labs, Ltd. NTBL|morphosys.com (MOR) - Total pendapatan perusahaan|NAYA Biosciences Inc - Pendapatan lan volume dodolan|AAPGV: Pendapatan perusahaan